Skip to main content

Peer Review reports

From: Efficacy and safety of ivermectin in the treatment of mild to moderate COVID-19 infection: a randomized, double-blind, placebo-controlled trial

Original Submission
23 Feb 2022 Submitted Original manuscript
4 May 2022 Reviewed Reviewer Report - Ines Rombach
23 May 2022 Reviewed Reviewer Report - Abhishek Abhishek
8 Jun 2022 Author responded Author comments - Thananda Trakarnvanich
Resubmission - Version 2
8 Jun 2022 Submitted Manuscript version 2
17 Jun 2022 Reviewed Reviewer Report - Ines Rombach
25 Jul 2022 Author responded Author comments - Thananda Trakarnvanich
Resubmission - Version 3
25 Jul 2022 Submitted Manuscript version 3
7 Aug 2022 Reviewed Reviewer Report - Ines Rombach
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
7 Aug 2022 Editorially accepted
26 Aug 2022 Article published 10.1186/s13063-022-06649-3

You can find further information about peer review here.

Back to article page